Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil

Background: Recommended standard treatment for leprosy is multidrugtherapy (MDT/WHO), consisting Rifampicin+Dapsone+Clofazimine. Other medications are recommended in cases of resistance, adverse reactions and intolerances, including ROM regimen, Rifampicin+Ofloxacin+Minocycline. Therefore, pharmacov...

Descripció completa

Dades bibliogràfiques

Autors principals:	Isadora Costa Celestino, Douglas Eulalio Antunes, Diogo Fernandes Santos, Victor Lemos Gimenes, Fabiane Mian de Souza, Isabela Maria Bernardes Goulart
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-03-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	leprosy drug-related side effects and adverse reactions Rifampicin Dapsone Clofazimine Ofloxacin
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1346169/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!